This feature is present in more than 90% of Lynch syndrome‐associated colorectal tumors in general and also in those associated with somatic or constitutional epigenetic silencing of the MLH1 gene 19, 39, 40, 41. This evidence concerns the gene MLH1 and colorectal neoplasm.